|

Ligufalimab Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: AK117

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • University of Texas Southwestern Medical Center1
  • Groupe Oncologie Radiotherapie Tete et Cou1

Indications

  • Cancer2
  • Liver Disease1
  • Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)1
  • Refractory Hepatocellular Carcinoma1
  • Biliary Tract Cancer1

Other1 trial

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN
Phase 3

Dallas, Texas1 trial

Ligufalimab and Cadonilimab in Advanced Liver Cancers

University of Texas Southwestern Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.